Merck launched the Mobius MyWay portfolio, a program designed to provide more flexibility, better supply predictability and shorter lead times for efficient and safe drug manufacture.   “We have the industry’s only comprehensive single-use solution, giving customers three different ways to create customizable assemblies,” said Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation at the life science business sector of Merck. “This is critical to ...